Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Neuroblastoma.

Maris JM, Hogarty MD, Bagatell R, Cohn SL.

Lancet. 2007 Jun 23;369(9579):2106-20. Review.

PMID:
17586306
2.

Molecular biology of neuroblastoma.

Castel V, Grau E, Noguera R, Martínez F.

Clin Transl Oncol. 2007 Aug;9(8):478-83. Review.

PMID:
17720650
3.

Neuroblastoma: biology and staging.

Mueller S, Matthay KK.

Curr Oncol Rep. 2009 Nov;11(6):431-8. Review.

PMID:
19840520
4.

[Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use].

Pérel Y, Valteau-Couanet D, Michon J, Lavrand F, Coze C, Bergeron C, Notz A, Plantaz D, Chastagner P, Bernard F, Thomas C, Rubie H.

Arch Pediatr. 2004 Jul;11(7):834-42. Review. French.

PMID:
15234382
5.

Genetic discoveries and treatment advances in neuroblastoma.

Bagatell R, Cohn SL.

Curr Opin Pediatr. 2016 Feb;28(1):19-25. doi: 10.1097/MOP.0000000000000296. Review.

6.

Neuroblastoma: biology and therapy.

Matthay KK.

Oncology (Williston Park). 1997 Dec;11(12):1857-66; discussion 1869-72, 1875. Review.

7.

Progress in treatment and risk stratification of neuroblastoma: impact on future clinical and basic research.

Øra I, Eggert A.

Semin Cancer Biol. 2011 Oct;21(4):217-28. doi: 10.1016/j.semcancer.2011.07.002. Epub 2011 Jul 20. Review.

PMID:
21798350
8.

Neuroblastoma.

Castleberry RP.

Eur J Cancer. 1997 Aug;33(9):1430-7; discussion 1437-8. Review.

PMID:
9337686
9.

The biologic basis for neuroblastoma heterogeneity and risk stratification.

Maris JM.

Curr Opin Pediatr. 2005 Feb;17(1):7-13. Review.

PMID:
15659956
10.

Neuroblastoma: biological insights into a clinical enigma.

Brodeur GM.

Nat Rev Cancer. 2003 Mar;3(3):203-16. Review.

PMID:
12612655
11.

Neuroblastoma: biology, prognosis, and treatment.

Park JR, Eggert A, Caron H.

Pediatr Clin North Am. 2008 Feb;55(1):97-120, x. doi: 10.1016/j.pcl.2007.10.014. Review.

PMID:
18242317
12.

Predicting outcomes for children with neuroblastoma.

Vermeulen J, De Preter K, Mestdagh P, Laureys G, Speleman F, Vandesompele J.

Discov Med. 2010 Jul;10(50):29-36. Review.

13.

The roles of microRNAs in neuroblastoma.

Mei H, Lin ZY, Tong QS.

World J Pediatr. 2014 Feb;10(1):10-6. doi: 10.1007/s12519-014-0448-2. Epub 2014 Jan 25. Review.

PMID:
24464658
14.

Global genomic and RNA profiles for novel risk stratification of neuroblastoma.

Ohira M, Nakagawara A.

Cancer Sci. 2010 Nov;101(11):2295-301. doi: 10.1111/j.1349-7006.2010.01681.x. Review.

15.

Biology and treatment of neuroblastoma.

Castleberry RP.

Pediatr Clin North Am. 1997 Aug;44(4):919-37. Review.

PMID:
9286292
16.

Clinical and biologic features in the prognosis and treatment of neuroblastoma.

Castleberry RP.

Curr Opin Oncol. 1992 Feb;4(1):116-23. Review.

PMID:
1591283
17.

Current and future strategies for relapsed neuroblastoma: challenges on the road to precision therapy.

Morgenstern DA, Baruchel S, Irwin MS.

J Pediatr Hematol Oncol. 2013 Jul;35(5):337-47. doi: 10.1097/MPH.0b013e318299d637. Review.

PMID:
23703550
18.

Progress towards personalized therapeutics: biologic- and risk-directed therapy for neuroblastoma.

Gustafson WC, Matthay KK.

Expert Rev Neurother. 2011 Oct;11(10):1411-23. doi: 10.1586/ern.11.103. Review.

PMID:
21955198
19.

Mechanisms of neuroblastoma regression.

Brodeur GM, Bagatell R.

Nat Rev Clin Oncol. 2014 Dec;11(12):704-13. doi: 10.1038/nrclinonc.2014.168. Epub 2014 Oct 21. Review.

20.

Treatment of high-risk neuroblastoma with anti-GD2 antibodies.

Castel V, Segura V, Cañete A.

Clin Transl Oncol. 2010 Dec;12(12):788-93. doi: 10.1007/s12094-010-0600-y. Review.

PMID:
21156409

Supplemental Content

Support Center